This report forecasts US pet supplement retail sales in nominal US dollars for 2024-2028. To illustrate historical trends, total retail sales are provided in an annual series from 2018-2023.
This report examines the US market for nutritional supplements for pets – primarily dogs, cats, birds, small mammals, and reptiles, collectively. The term “supplement” as used in this report refers to products sold in traditional supplement forms including pills, tablets, powders, liquids, and sprays. The primary focus is on products for dogs and cats, which account for a large preponderance of US retail sales, but coverage also extends to other types of companion animals.
Specifically excluded are: pet foods marketed as complete and balanced diets, including those featuring novel functional ingredients; functional treats – products with functional benefits due to nutritional supplement-based ingredients but marketed primarily as treats (covered in Packaged Facts’ Pet Treats and Chews in the US); supplements for equines; supplements for fish, most of which are water treatment products to control algae, fungi, parasites, etc.
Freedonia quantifies trends in various measures of growth and volatility. Growth (or decline) expressed as an average annual growth rate (AAGR) is the least squares growth rate, which takes into account all available datapoints over a period. Growth calculated as a compound annual growth rate (CAGR) employs, by definition, only the first and last datapoints over a period. The CAGR is used to describe forecast growth, defined as the expected trend beginning in the base year and ending in the forecast year. Readers are encouraged to consider historical volatility when assessing particular annual values along the forecast trend, including in the forecast year.
A full outline of report items by page is available in the Table of Contents.
Related NAICS Codes:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook